drugset / Trial / NCT01291901

NP2 Enkephalin For Treatment of Intractable Cancer Pain

NCT01291901 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to examine the impact of intradermal delivery of NP2 on pain scores and pain medication usage in subjects with intractable pain due to malignant disease. A second purpose is to confirm safety and secondary efficacy measurements.

Timeline

Start
2011-01
Primary completion
2012-07
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject NP2 Unknown 1 ml Intrathecal

Indications